Associated Genetic Biomarkers
Associated Diseases


Gene Location [1]
Variant Type

BCL6 Amplification is present in 0.40% of AACR GENIE cases, with squamous cell lung carcinoma, high grade ovarian serous adenocarcinoma, anal squamous cell carcinoma, breast invasive ductal carcinoma, and oral cavity squamous cell carcinoma having the greatest prevalence [4].

Top Disease Cases with BCL6 Amplification

Significance of BCL6 Amplification in Diseases

Mature B-Cell Lymphoma/Leukemia +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015.

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.